Seroxat CR Indications/Uses

Adults: Major Depressive Disorder: SEROXAT CR tablets are indicated for the treatment of major depressive disorder.
Panic Disorder: SEROXAT CR tablets have been shown to be effective in the treatment of panic disorder with or without agoraphobia.
Premenstrual Dysphoric Disorder: SEROXAT CR tablets are indicated for the treatment of premenstrual dysphoric disorder (PMDD).
Paroxetine has not been evaluated beyond 3 menstrual cycles in controlled clinical trials for the treatment of PMDD.
Social Anxiety Disorder/Social Phobia: SEROXAT CR Tablets have been shown to be effective in the treatment of Social Anxiety Disorder/Social Phobia.
The effectiveness of SEROXAT CR tablets in the long-term treatment of Social Anxiety Disorder/Social Phobia has not been evaluated. Therefore, if SEROXAT CR tablets are to be administered for extended periods in the treatment of Social Anxiety Disorder/Social Phobia, the physician should periodically re-evaluate the long-term usefulness of SEROXAT CR for the individual patient.
Children and adolescents (less than 18 years): All Indications: SEROXAT CR is not indicated for use in children or adolescents aged less than 18 years (see Precautions).
The efficacy of SEROXAT CR tablets has not been studied in children or adolescents aged less than 18 years; however, controlled clinical studies with SEROXAT IR (immediate release) tablets in children and adolescents with major depressive disorder failed to demonstrate efficacy, and do not support the use of SEROXAT in the treatment of depression in this population (see Precautions).
The safety and efficacy of SEROXAT in children aged less than 7 years has not been studied.